Literature DB >> 16160014

Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation.

Lisbeth A Welniak1, Dmitry V Kuprash, Alexei V Tumanov, Angela Panoskaltsis-Mortari, Bruce R Blazar, Kai Sun, Sergei A Nedospasov, William J Murphy.   

Abstract

Graft-versus-host disease (GVHD) is a multistep disease process following allogeneic bone marrow transplantation (BMT). It has been postulated that the induction of acute GVHD requires the presence of Peyer patches (PPs). A new tumor necrosis factor (TNF)-deficient strain has been developed that totally lacks PPs and displays the defects characteristic of TNF ablation but not lymphotoxin-associated defects characterized by lack of both PPs and lymph nodes. To determine the necessity of PPs in acute lethal GVHD induction, we transplanted full major histocompatibility complex (MHC)-mismatched grafts into myeloablated TNF knockout recipients. No differences in the survival or GVHD-associated histopathologic lesions were observed between the recipients. We conclude that neither PPs nor host TNF-alpha is required for the development of acute lethal GVHD in mice that undergo myeloablative conditioning and allogeneic BMT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160014      PMCID: PMC1895345          DOI: 10.1182/blood-2004-11-4565

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning.

Authors:  Christian A Wysocki; Susan B Burkett; Angela Panoskaltsis-Mortari; Suzanne L Kirby; Andrew D Luster; Karen McKinnon; Bruce R Blazar; Jonathan S Serody
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

2.  Novel tumor necrosis factor-knockout mice that lack Peyer's patches.

Authors:  Dmitry V Kuprash; Alexei V Tumanov; Dmitry J Liepinsh; Ekaterina P Koroleva; Marina S Drutskaya; Andrei A Kruglov; Alexander N Shakhov; Eileen Southon; William J Murphy; Lino Tessarollo; Sergei I Grivennikov; Sergei A Nedospasov
Journal:  Eur J Immunol       Date:  2005-05       Impact factor: 5.532

3.  Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting.

Authors:  H Gu; Y R Zou; K Rajewsky
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

4.  Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation.

Authors:  Cornelius Schmaltz; Onder Alpdogan; Stephanie J Muriglan; Barry J Kappel; Jimmy A Rotolo; Eric T Ricchetti; Andrew S Greenberg; Lucy M Willis; George F Murphy; James M Crawford; Marcel R M van den Brink
Journal:  Blood       Date:  2002-11-07       Impact factor: 22.113

5.  Role of gut cryptopatches in early extrathymic maturation of intestinal intraepithelial T cells.

Authors:  T Oida; K Suzuki; M Nanno; Y Kanamori; H Saito; E Kubota; S Kato; M Itoh; S Kaminogawa; H Ishikawa
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

6.  The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.

Authors:  B P Giroir; J H Johnson; T Brown; G L Allen; B Beutler
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease.

Authors:  Aleksandra Petrovic; Onder Alpdogan; Lucy M Willis; Jeffrey M Eng; Andrew S Greenberg; Barry J Kappel; Chen Liu; George J Murphy; Glenn Heller; Marcel R M van den Brink
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

8.  An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease.

Authors:  Lisbeth A Welniak; Zhao Wang; Kai Sun; William Kuziel; Miriam R Anver; Bruce R Blazar; William J Murphy
Journal:  Exp Hematol       Date:  2004-03       Impact factor: 3.084

9.  Gut injury in mouse graft-versus-host reaction. Study of its occurrence and mechanisms.

Authors:  D Guy-Grand; P Vassalli
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

10.  Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction.

Authors:  Masako Murai; Hiroyuki Yoneyama; Taichi Ezaki; Makoto Suematsu; Yuya Terashima; Akihisa Harada; Hiromasa Hamada; Hitoshi Asakura; Hiromichi Ishikawa; Kouji Matsushima
Journal:  Nat Immunol       Date:  2003-01-13       Impact factor: 25.606

View more
  18 in total

1.  Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs.

Authors:  Andreas Beilhack; Stephan Schulz; Jeanette Baker; Georg F Beilhack; Ryosei Nishimura; Enosh M Baker; Gilad Landan; Edward I Herman; Eugene C Butcher; Christopher H Contag; Robert S Negrin
Journal:  Blood       Date:  2007-11-07       Impact factor: 22.113

2.  Allospecific CD4(+) effector memory T cells do not induce graft-versus-host disease in mice.

Authors:  Ping Zhang; Jieying Wu; Divino Deoliveira; Nelson J Chao; Benny J Chen
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-15       Impact factor: 5.742

Review 3.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

4.  Radiation and host retinoic acid signaling promote the induction of gut-homing donor T cells after allogeneic hematopoietic stem cell transplantation.

Authors:  Jianwei Zheng; Brian Taylor; Joseph Dodge; Allison Stephans; Song Guo Zheng; Qiang Chen; Xiao Chen
Journal:  Am J Transplant       Date:  2019-07-15       Impact factor: 8.086

Review 5.  Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).

Authors:  Bruce R Blazar; William J Murphy
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

6.  Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activation.

Authors:  Ines A Silva; Krystyna Olkiewicz; David Askew; Jacquelyn M Fisher; Meghana N Chaudhary; Kevin M Vannella; Daphne T Deurloo; Sung W Choi; Elizabeth M Pierce; Shawn G Clouthier; Chen Liu; Kenneth R Cooke
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-01       Impact factor: 5.742

7.  Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells.

Authors:  Britt E Anderson; Patricia A Taylor; Jennifer M McNiff; Dhanpat Jain; Anthony J Demetris; Angela Panoskaltsis-Mortari; Ann Ager; Bruce R Blazar; Warren D Shlomchik; Mark J Shlomchik
Journal:  Blood       Date:  2008-02-19       Impact factor: 22.113

Review 8.  Graft-versus-host disease.

Authors:  James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Journal:  Lancet       Date:  2009-03-11       Impact factor: 79.321

Review 9.  Acute graft-versus-host disease: from the bench to the bedside.

Authors:  Gerard Socié; Bruce R Blazar
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

Review 10.  Role of beta7 integrins in intestinal lymphocyte homing and retention.

Authors:  G Gorfu; J Rivera-Nieves; K Ley
Journal:  Curr Mol Med       Date:  2009-09       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.